Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    17174180 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: sirolimus-eluting stent, zotarolimus-eluting stent
2 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
3 Recruiting Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: Hybrid sirolimus- and everolimus-eluting stents (ORSIRO, XIENCE PRIME)

Indicates status has not been verified in more than two years